Tools are exclusively owned or rights are held by an individual or organization and may require purchase, membership, or an account to access.
Describes and compares pharmacological treatment options for individuals with AUD, including FDA- approved medications acamprosate, disufiram, and naltrexone, as well as two other evidence-based treatments that are not yet FDA approved, topiramate and gabapentin; includes diagnosis of AUD, definitions of binge drinking and “at risk” drinking, and a case vignette; up to 1 AMA PRA Category 1 Credit™ for continuing education
Discusses the importance of language when discussing substance use and reviews ways to improve language used during clinical encounters to improve patient care
Module that includes an overview of substance use disorders;discusses neurobiological responses to substances, theories that explain the disorders, and integrated care for substance use disorder
Review of systematic reviews that evaluated the effectiveness of brief interventions in primary healthcare settings to decrease alcohol consumption in non-alcoholic adult drinkers; found that brief interventions have a moderate effect on reducing alcohol consumption people who consume excessive amounts of alcohol
Online course for providers on the essential components of motivational interviewing; offers 4.0 hours of continuing education credit
Email Updates